These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25403298)

  • 1. [New possibilities of pharmacotherapy in cardiovascular patients with mental disorders].
    Medvedev VE; Frolova VI; Epifanov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):30-7. PubMed ID: 25403298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pantogam in daily psychiatric practice].
    Kontsevoĭ VA; Rotshteĭn VG; Bogdan MN; Riakhovskiĭ VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):34-9. PubMed ID: 18427457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pantogam in the treatment of patients with organic brain lesions of different genesis].
    Rogacheva TA; Mel'nikova TS; Krasnoslobodtseva LA; Nazmetdinova DM; Lapin IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):34-9. PubMed ID: 21183912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative investigation of calcium ketopantoylaminobutyrate and pantogam: tranquilizer activity].
    Karaev AL; Kozlova GS; Smirnova TN; Gunar VI
    Eksp Klin Farmakol; 2004; 67(6):20-2. PubMed ID: 15707008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventive and cessation therapy of mental disorders in patients with the acute coronary syndrome].
    Medvedev VE; Epifanov AV; Zverev KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):42-8. PubMed ID: 22810740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of pantogam in the treatment of hyperkinetic disorders in children].
    Sukhotina NK; Konovalova VV; Kryzhanovskaia IL; Kupriianova TA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):24-8. PubMed ID: 21311483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and tolerability of pantogam activ in patients with partial epilepsy].
    Poverennova IE; Iakunina AV; Kalinin VA; Savel'eva NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2):54-9. PubMed ID: 21350425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possible applications of rac-hopantenic acid in the treatment of anxiety and depressive disorders in patients with chronic cerebral ischemia].
    Gekht AB; Kanaeva LS; Avedisova AS; Marachev MP; Zakharova KV; Dashkina GK; Kulikova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):45-57. PubMed ID: 28091501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antihypoxant and antiamnesic effects of calcium ketopantoylaminobutyrate].
    Karavaev AL; Kozlova GS; Smirnova TN; Gunar VI
    Eksp Klin Farmakol; 2005; 68(6):9-11. PubMed ID: 16405026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological effects and clinical application of pantogam and pantogam active].
    Voronina TA; Litvinova SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):132-139. PubMed ID: 28884730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nootropic agents in the complex treatment of patients with traumatic epilepsy].
    Lekomtsev VT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(6):68-72. PubMed ID: 2171277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pantogam activ (D-, L-hopantenic acid) in the treatment of cognitive and anxiety disorders in patients with arterial hypertension].
    Smulevich AB; Volel BA; Ternovaya ES; Nikitina YM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):40-49. PubMed ID: 26978493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of combat stress in the development of chronic pain syndrom in veterans and its treatment by pantogam active].
    Pal'tsev AI; Torgashov MN; Vorontsova IuS; Baiandina EV; Luniakina SB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):43-6. PubMed ID: 21246890
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiepileptic drugs in the combined medicinal prevention of motion sickness].
    Karkishchenko NN; Dimitriadi NA
    Kosm Biol Aviakosm Med; 1991; 25(1):21-3. PubMed ID: 2046293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of nootropic agents on visual functions and lacrimal antioxidative activity in patients with primary open-angle glaucoma].
    Davydova NG; Kuznetsova TP; Borisova SA; Abdulkadyrova MZh
    Vestn Oftalmol; 2006; 122(6):42-5. PubMed ID: 17217203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A differential approach to the improvement of prevention and correction of neuroleptic side extrapyramidal disorders with pantogam activ in patients with schizophrenia].
    Tiganov AS; Panteleeva GP; Abramova LI; Bologov PV; Kananovich PS; Omel'chenko MA; Nikiforova IY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):72-80. PubMed ID: 28374697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Augmented antipsychotic therapy with pantogam active in patients with schizophrenia].
    Medvedev VE; Frolova VI; Gushanskaya EV; Ter-Israelyan AU
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):28-34. PubMed ID: 26356612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Attention-deficit hyperactivity disorder: determination of the optimal medical treatment duration].
    Zavadenko NN; Suvorinova NIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):28-32. PubMed ID: 22500309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychophysiological effects of combined administration of pantogam and potassium orotate in patients with neurotic disorders].
    Ben'kovich BI; Gorshkova IA; Gershanovich II; Faĭzulloev AZ
    Eksp Klin Farmakol; 2001; 64(3):26-8. PubMed ID: 11558433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pantogam active in the complex treatment of dystonic hyperkineses].
    Katunina EA; Malykhina EA; Avanesova OV; Makarova AA; Abdurakhmanova EK; Gridiakin VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):57-61. PubMed ID: 21389940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.